Global Safety Lancets for Diabetes Market Research Report 2024(Status and Outlook)

Global Safety Lancets for Diabetes Market Research Report 2024(Status and Outlook)



Report Overview: Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated. The Global Safety Lancets for Diabetes Market Size was estimated at USD 546.12 million in 2023 and is projected to reach USD 740.25 million by 2029, exhibiting a CAGR of 5.20% during the forecast period. This report provides a deep insight into the global Safety Lancets for Diabetes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Safety Lancets for Diabetes Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Safety Lancets for Diabetes market in any manner. Global Safety Lancets for Diabetes Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Roche BD Ascensia Lifescan B. Braun Terumo Nipro Cardinal Health ARKRAY ICU Medical Owen Mumford HemoCue Greiner Bio One HTL-STREFA Sarstedt Market Segmentation (by Type) Safety Lancets with Needle Safety Lancets with Blade Market Segmentation (by Application) Hospital & Clinics Home Other Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Safety Lancets for Diabetes Market • Overview of the regional outlook of the Safety Lancets for Diabetes Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Note: this report may need to undergo a final check or review and this could take about 48 hours. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Safety Lancets for Diabetes Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Safety Lancets for Diabetes
1.2 Key Market Segments
1.2.1 Safety Lancets for Diabetes Segment by Type
1.2.2 Safety Lancets for Diabetes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Safety Lancets for Diabetes Market Overview
2.1 Global Market Overview
2.1.1 Global Safety Lancets for Diabetes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Safety Lancets for Diabetes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Safety Lancets for Diabetes Market Competitive Landscape
3.1 Global Safety Lancets for Diabetes Sales by Manufacturers (2019-2024)
3.2 Global Safety Lancets for Diabetes Revenue Market Share by Manufacturers (2019-2024)
3.3 Safety Lancets for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Safety Lancets for Diabetes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Safety Lancets for Diabetes Sales Sites, Area Served, Product Type
3.6 Safety Lancets for Diabetes Market Competitive Situation and Trends
3.6.1 Safety Lancets for Diabetes Market Concentration Rate
3.6.2 Global 5 and 10 Largest Safety Lancets for Diabetes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Safety Lancets for Diabetes Industry Chain Analysis
4.1 Safety Lancets for Diabetes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Safety Lancets for Diabetes Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Safety Lancets for Diabetes Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Safety Lancets for Diabetes Sales Market Share by Type (2019-2024)
6.3 Global Safety Lancets for Diabetes Market Size Market Share by Type (2019-2024)
6.4 Global Safety Lancets for Diabetes Price by Type (2019-2024)
7 Safety Lancets for Diabetes Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Safety Lancets for Diabetes Market Sales by Application (2019-2024)
7.3 Global Safety Lancets for Diabetes Market Size (M USD) by Application (2019-2024)
7.4 Global Safety Lancets for Diabetes Sales Growth Rate by Application (2019-2024)
8 Safety Lancets for Diabetes Market Segmentation by Region
8.1 Global Safety Lancets for Diabetes Sales by Region
8.1.1 Global Safety Lancets for Diabetes Sales by Region
8.1.2 Global Safety Lancets for Diabetes Sales Market Share by Region
8.2 North America
8.2.1 North America Safety Lancets for Diabetes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Safety Lancets for Diabetes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Safety Lancets for Diabetes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Safety Lancets for Diabetes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Safety Lancets for Diabetes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Safety Lancets for Diabetes Basic Information
9.1.2 Roche Safety Lancets for Diabetes Product Overview
9.1.3 Roche Safety Lancets for Diabetes Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Safety Lancets for Diabetes SWOT Analysis
9.1.6 Roche Recent Developments
9.2 BD
9.2.1 BD Safety Lancets for Diabetes Basic Information
9.2.2 BD Safety Lancets for Diabetes Product Overview
9.2.3 BD Safety Lancets for Diabetes Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Safety Lancets for Diabetes SWOT Analysis
9.2.6 BD Recent Developments
9.3 Ascensia
9.3.1 Ascensia Safety Lancets for Diabetes Basic Information
9.3.2 Ascensia Safety Lancets for Diabetes Product Overview
9.3.3 Ascensia Safety Lancets for Diabetes Product Market Performance
9.3.4 Ascensia Safety Lancets for Diabetes SWOT Analysis
9.3.5 Ascensia Business Overview
9.3.6 Ascensia Recent Developments
9.4 Lifescan
9.4.1 Lifescan Safety Lancets for Diabetes Basic Information
9.4.2 Lifescan Safety Lancets for Diabetes Product Overview
9.4.3 Lifescan Safety Lancets for Diabetes Product Market Performance
9.4.4 Lifescan Business Overview
9.4.5 Lifescan Recent Developments
9.5 B. Braun
9.5.1 B. Braun Safety Lancets for Diabetes Basic Information
9.5.2 B. Braun Safety Lancets for Diabetes Product Overview
9.5.3 B. Braun Safety Lancets for Diabetes Product Market Performance
9.5.4 B. Braun Business Overview
9.5.5 B. Braun Recent Developments
9.6 Terumo
9.6.1 Terumo Safety Lancets for Diabetes Basic Information
9.6.2 Terumo Safety Lancets for Diabetes Product Overview
9.6.3 Terumo Safety Lancets for Diabetes Product Market Performance
9.6.4 Terumo Business Overview
9.6.5 Terumo Recent Developments
9.7 Nipro
9.7.1 Nipro Safety Lancets for Diabetes Basic Information
9.7.2 Nipro Safety Lancets for Diabetes Product Overview
9.7.3 Nipro Safety Lancets for Diabetes Product Market Performance
9.7.4 Nipro Business Overview
9.7.5 Nipro Recent Developments
9.8 Cardinal Health
9.8.1 Cardinal Health Safety Lancets for Diabetes Basic Information
9.8.2 Cardinal Health Safety Lancets for Diabetes Product Overview
9.8.3 Cardinal Health Safety Lancets for Diabetes Product Market Performance
9.8.4 Cardinal Health Business Overview
9.8.5 Cardinal Health Recent Developments
9.9 ARKRAY
9.9.1 ARKRAY Safety Lancets for Diabetes Basic Information
9.9.2 ARKRAY Safety Lancets for Diabetes Product Overview
9.9.3 ARKRAY Safety Lancets for Diabetes Product Market Performance
9.9.4 ARKRAY Business Overview
9.9.5 ARKRAY Recent Developments
9.10 ICU Medical
9.10.1 ICU Medical Safety Lancets for Diabetes Basic Information
9.10.2 ICU Medical Safety Lancets for Diabetes Product Overview
9.10.3 ICU Medical Safety Lancets for Diabetes Product Market Performance
9.10.4 ICU Medical Business Overview
9.10.5 ICU Medical Recent Developments
9.11 Owen Mumford
9.11.1 Owen Mumford Safety Lancets for Diabetes Basic Information
9.11.2 Owen Mumford Safety Lancets for Diabetes Product Overview
9.11.3 Owen Mumford Safety Lancets for Diabetes Product Market Performance
9.11.4 Owen Mumford Business Overview
9.11.5 Owen Mumford Recent Developments
9.12 HemoCue
9.12.1 HemoCue Safety Lancets for Diabetes Basic Information
9.12.2 HemoCue Safety Lancets for Diabetes Product Overview
9.12.3 HemoCue Safety Lancets for Diabetes Product Market Performance
9.12.4 HemoCue Business Overview
9.12.5 HemoCue Recent Developments
9.13 Greiner Bio One
9.13.1 Greiner Bio One Safety Lancets for Diabetes Basic Information
9.13.2 Greiner Bio One Safety Lancets for Diabetes Product Overview
9.13.3 Greiner Bio One Safety Lancets for Diabetes Product Market Performance
9.13.4 Greiner Bio One Business Overview
9.13.5 Greiner Bio One Recent Developments
9.14 HTL-STREFA
9.14.1 HTL-STREFA Safety Lancets for Diabetes Basic Information
9.14.2 HTL-STREFA Safety Lancets for Diabetes Product Overview
9.14.3 HTL-STREFA Safety Lancets for Diabetes Product Market Performance
9.14.4 HTL-STREFA Business Overview
9.14.5 HTL-STREFA Recent Developments
9.15 Sarstedt
9.15.1 Sarstedt Safety Lancets for Diabetes Basic Information
9.15.2 Sarstedt Safety Lancets for Diabetes Product Overview
9.15.3 Sarstedt Safety Lancets for Diabetes Product Market Performance
9.15.4 Sarstedt Business Overview
9.15.5 Sarstedt Recent Developments
10 Safety Lancets for Diabetes Market Forecast by Region
10.1 Global Safety Lancets for Diabetes Market Size Forecast
10.2 Global Safety Lancets for Diabetes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Safety Lancets for Diabetes Market Size Forecast by Country
10.2.3 Asia Pacific Safety Lancets for Diabetes Market Size Forecast by Region
10.2.4 South America Safety Lancets for Diabetes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Safety Lancets for Diabetes by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Safety Lancets for Diabetes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Safety Lancets for Diabetes by Type (2025-2030)
11.1.2 Global Safety Lancets for Diabetes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Safety Lancets for Diabetes by Type (2025-2030)
11.2 Global Safety Lancets for Diabetes Market Forecast by Application (2025-2030)
11.2.1 Global Safety Lancets for Diabetes Sales (K Units) Forecast by Application
11.2.2 Global Safety Lancets for Diabetes Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings